Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 3;10(7):1622-1632.
doi: 10.7150/jca.27780. eCollection 2019.

The Prospective Value of Dopamine Receptors on Bio-Behavior of Tumor

Xu Wang  1   2 , Zhi-Bin Wang  1   2 , Chao Luo  1   2   3 , Xiao-Yuan Mao  1   2 , Xi Li  1   2 , Ji-Ye Yin  1   2 , Wei Zhang  1   2   4 , Hong-Hao Zhou  1   2   4 , Zhao-Qian Liu  1   2   4
Affiliations
Review

The Prospective Value of Dopamine Receptors on Bio-Behavior of Tumor

Xu Wang et al. J Cancer. .

Abstract

Dopamine receptors are belong to the family of G protein-coupled receptor. There are five types of dopamine receptor (DR), including DRD1, DRD2, DRD3, DRD4, and DRD5, which are divided into two major groups: the D1-like receptors (DRD1 and DRD5), and the D2-like receptors (DRD2, DRD3, and DRD4). Dopamine receptors are involved in all of the physiological functions of dopamine, including the autonomic movement, emotion, hormonal regulation, dopamine-induced immune effects, and tumor behavior, and so on. Increasing evidence shows that dopamine receptors are associated with the regulation of tumor behavior, such as tumor cell death, proliferation, invasion, and migration. Recently, some studies showed that dopamine receptors could regulate several ways of death of the tumor cell, including apoptosis, autophagy-induced death, and ferroptosis, which cannot only directly affect tumor behavior, but also limit tumor progress via activating tumor immunity. In this review, we focus mainly on the function of the dopamine receptor on Bio-behavior of tumor as a potential therapeutic target.

Keywords: autophagy; dopamine receptor; ferroptosis; tumor immunity.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

References

    1. Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011;63:182–217. - PubMed
    1. Peters MA, Walenkamp AM, Kema IP, Meijer C, de Vries EG, Oosting SF. Dopamine and serotonin regulate tumor behavior by affecting angiogenesis. Drug Resist Updat. 2014;17:96–104. - PubMed
    1. Eisenhofer G, Aneman A, Friberg P, Hooper D, Fandriks L, Lonroth H. et al. Substantial production of dopamine in the human gastrointestinal tract. The Journal of clinical endocrinology and metabolism. 1997;82:3864–71. - PubMed
    1. Vallone D, Picetti R, Borrelli E. Structure and function of dopamine receptors. Neuroscience and biobehavioral reviews. 2000;24:125–32. - PubMed
    1. Basu B, Sarkar C, Chakroborty D, Ganguly S, Shome S, Dasgupta PS. et al. D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in jurkat T leukemic cells. The Journal of biological chemistry. 2010;285:27026–32. - PMC - PubMed

LinkOut - more resources